Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2023 Nov;61(6):802-814.
doi: 10.1016/j.resinv.2023.08.008. Epub 2023 Sep 30.

Comprehensive analysis of long COVID in a Japanese nationwide prospective cohort study

Hideki Terai  1 Makoto Ishii  2 Ryo Takemura  3 Ho Namkoong  4 Kyoko Shimamoto  5 Katsunori Masaki  6 Takae Tanosaki  6 Shotaro Chubachi  6 Emiko Matsuyama  6 Reina Hayashi  6 Takashi Shimada  6 Lisa Shigematsu  6 Fumimaro Ito  6 Masanori Kaji  6 Hatsuyo Takaoka  6 Momoko Kurihara  6 Kensuke Nakagawara  6 Saki Tomiyasu  6 Kotaro Sasahara  6 Ayaka Saito  6 Shiro Otake  6 Shuhei Azekawa  6 Masahiko Okada  6 Takahiro Fukushima  6 Atsuho Morita  6 Hiromu Tanaka  6 Keeya Sunata  6 Masato Asaoka  6 Miyuki Nishie  6 Taro Shinozaki  6 Toshiki Ebisudani  6 Yuto Akiyama  6 Akifumi Mitsuishi  6 Shingo Nakayama  6 Takunori Ogawa  6 Kaori Sakurai  6 Misato Irie  6 Kazuma Yagi  6 Keiko Ohgino  6 Jun Miyata  6 Hiroki Kabata  6 Shinnosuke Ikemura  6 Hirofumi Kamata  6 Hiroyuki Yasuda  6 Ichiro Kawada  6 Ryusei Kimura  3 Masahiro Kondo  3 Toshiki Iwasaki  3 Noriyuki Ishida  3 Gaku Hiruma  3 Naoki Miyazaki  3 Yoshiki Ishibashi  7 Sei Harada  7 Takanori Fujita  8 Daisuke Ito  9 Shogyoku Bun  10 Hajime Tabuchi  10 Sho Kanzaki  11 Eisuke Shimizu  12 Keitaro Fukuda  13 Jun Yamagami  13 Keigo Kobayashi  14 Toshiyuki Hirano  14 Takashi Inoue  14 Mizuha Haraguchi  15 Junko Kagyo  15 Tetsuya Shiomi  15 Ho Lee  16 Kai Sugihara  17 Nao Omori  17 Koichi Sayama  17 Kengo Otsuka  18 Naoki Miyao  18 Toshio Odani  19 Mayuko Watase  20 Takao Mochimaru  21 Ryosuke Satomi  21 Yoshitaka Oyamada  21 Keita Masuzawa  22 Takanori Asakura  23 Sohei Nakayama  22 Yusuke Suzuki  22 Rie Baba  24 Satoshi Okamori  25 Daisuke Arai  24 Ichiro Nakachi  24 Naota Kuwahara  26 Akiko Fujiwara  26 Takenori Oakada  26 Takashi Ishiguro  27 Taisuke Isosno  27 Yasushi Makino  28 Shuko Mashimo  28 Tatsuya Kaido  28 Naoto Minematsu  29 Soichiro Ueda  30 Kazuhiro Minami  30 Rie Hagiwara  30 Tadashi Manabe  31 Takahiro Fukui  32 Yohei Funatsu  32 Hidefumi Koh  32 Takashi Yoshiyama  33 Hiroyuki Kokuto  33 Tatsuya Kusumoto  34 Ayano Oashi  35 Masayoshi Miyawaki  35 Fumitake Saito  35 Tetsuo Tani  36 Kota Ishioka  37 Saeko Takahashi  37 Morio Nakamura  37 Norihiro Harada  38 Hitoshi Sasano  38 Ai Goto  38 Yu Kusaka  39 Takehiko Ohba  39 Yasushi Nakano  40 Kazumi Nishio  40 Yukiko Nakajima  41 Shoji Suzuki  42 Shuichi Yoshida  42 Hiroki Tateno  42 Nobuhiro Kodama  43 Maeda Shunsuke  43 Satoshi Sakamoto  44 Masaki Okamoto  45 Yoji Nagasaki  46 Akira Umeda  47 Kazuya Miyagawa  48 Hisato Shimada  48 Kazuto Hagimura  49 Kengo Nagashima  3 Toshiro Sato  50 Yasunori Sato  51 Naoki Hasegawa  52 Toru Takebayashi  7 Jin Nakahara  53 Masaru Mimura  10 Kaoru Ogawa  11 Shigeto Shimmura  12 Kazuno Negishi  12 Kazuo Tsubota  12 Masayuki Amagai  13 Rei Goto  54 Yoko Ibuka  55 Yuko Kitagawa  56 Takanori Kanai  57 Koichi Fukunaga  58
Affiliations
Multicenter Study

Comprehensive analysis of long COVID in a Japanese nationwide prospective cohort study

Hideki Terai et al. Respir Investig. 2023 Nov.

Abstract

Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread rapidly since 2019, and the number of reports regarding long COVID has increased. Although the distribution of long COVID depends on patient characteristics, epidemiological data on Japanese patients are limited. Hence, this study aimed to investigate the distribution of long COVID in Japanese patients. This study is the first nationwide Japanese prospective cohort study on long COVID.

Methods: This multicenter, prospective cohort study enrolled hospitalized COVID-19 patients aged ≥18 years at 26 Japanese medical institutions. In total, 1200 patients were enrolled. Clinical information and patient-reported outcomes were collected from medical records, paper questionnaires, and smartphone applications.

Results: We collected data from 1066 cases with both medical records and patient-reported outcomes. The proportion of patients with at least one symptom decreased chronologically from 93.9% (947/1009) during hospitalization to 46.3% (433/935), 40.5% (350/865), and 33.0% (239/724) at 3, 6, and 12 months, respectively. Patients with at least one long COVID symptom showed lower quality of life and scored higher on assessments for depression, anxiety, and fear of COVID-19. Female sex, middle age (41-64 years), oxygen requirement, and critical condition during hospitalization were risk factors for long COVID.

Conclusions: This study elucidated the symptom distribution and risks of long COVID in the Japanese population. This study provides reference data for future studies of long COVID in Japan.

Keywords: General fatigue; Oxygen requirement; Patient-reported outcome; Post-COVID-19 conditions; Risk factors.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Norihiro Harada reports personal fees from AstraZeneca K.K., GlaxoSmithKline, Kyorin, Novartis Japan, Sanofi and grants from AstraZeneca, Daikin, Kyorin, SRL Medisearch, outside the submitted work. Other authors have no conflicts of interest.

Publication types

LinkOut - more resources